← Back to Clinical Trials
Recruiting NCT06500078

NCT06500078 Effects of Intermittent Dietary Restriction on Cardiometabolic Risk in School-aged Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06500078
Status Recruiting
Phase
Sponsor Children's Hospital of Fudan University
Condition Cardiovascular Syndrome, Metabolic
Study Type INTERVENTIONAL
Enrollment 324 participants
Start Date 2024-07-13
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Intermittent dietary restrictionGeneral health education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 324 participants in total. It began in 2024-07-13 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized trial aims to evaluate the health-promoting effects of intermittent dietary restrictions, including intermittent low-carbohydrate diet (ILCD) and calorie restriction (ICR), in school-aged children with cardiometabolic risk (CMR) compared with general health education based on dietary and physical activity guidelines for Chinese children.

Eligibility Criteria

Inclusion Criteria: * Aged 7-18 years at baseline. * At least one of the following cardio-metabolic abnormalities: 1. Prediabetes (Impaired fasting glucose: 5.6 ≤ fasting blood glucose level ≤ 6.9 mmol/L; or Impaired glucose tolerance: 7.8 ≤ blood glucose level after 2 hours postprandial ≤ 11.0 mmol/L). 2. Lipid abnormalities (High-density lipoprotein cholesterol ≤ 1.04 mmol/L; or Low-density lipoprotein cholesterol ≥ 3.37 mmol/L; or Triglycerides ≥ 1.70 mmol/L, or Total cholesterol ≥ 5.18 mmol/L). 3. Elevated blood pressure (Systolic/diastolic blood pressure consistently higher than the 90th percentile for gender, age, and height; or systolic/diastolic blood pressure ≥ 120/80 mmHg). Exclusion Criteria: * Previously diagnosed with heart failure, severe malnutrition, immune deficiency, liver or kidney disease, cancer, or other diseases deemed unsuitable for participation. * Had a history of bariatric surgery. * Used weight loss pills or supplements in the last three months. * Other situations unsuitable for participation.

Contact & Investigator

Central Contact

Yalan Dou

✉ yldou16@fudan.edu.cn

📞 +86 021 64932921

Frequently Asked Questions

Who can join the NCT06500078 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 18 Years, studying Cardiovascular Syndrome, Metabolic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06500078 currently recruiting?

Yes, NCT06500078 is actively recruiting participants. Contact the research team at yldou16@fudan.edu.cn for enrollment information.

Where is the NCT06500078 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT06500078 clinical trial?

NCT06500078 is sponsored by Children's Hospital of Fudan University. The trial plans to enroll 324 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology